{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:36:42Z","timestamp":1648654602683},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12325-015-0203-7","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T08:05:20Z","timestamp":1429085120000},"page":"381-386","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does Defibrotide Induce a Delay to Polymorphonuclear Neutrophil Engraftment After Hematopoietic Stem Cell Transplantation? Observation in a Pediatric Population"],"prefix":"10.1007","volume":"32","author":[{"given":"Natalia","family":"Maximova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pizzol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagua","family":"Giurici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Granzotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"203_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.05.001","volume":"59","author":"R Pescador","year":"2013","unstructured":"Pescador R, Capuzzi L, Mantovani M, Fulgenzi A, Ferrero ME. Defibrotide: properties and clinical use of an old\/new drug. Vascul Pharmacol. 2013;59:1\u201310.","journal-title":"Vascul Pharmacol"},{"key":"203_CR2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","volume":"16","author":"RG Richardson","year":"2010","unstructured":"Richardson RG, Soiffer RJ, Antin JH, et al. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant. 2010;16:1005\u201317.","journal-title":"Biol Blood Marrow Transplant."},{"key":"203_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00024382-199609010-00004","volume":"6","author":"R Scalia","year":"1996","unstructured":"Scalia R, Pearlman S, Campbell B, Lefer AM. Time course of endothelial dysfunction and neutrophil adherence and infiltration during murine traumatic shock. Shock. 1996;6:177\u201382.","journal-title":"Shock"},{"key":"203_CR4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00007890-199310000-00029","volume":"56","author":"M Ferraresso","year":"1993","unstructured":"Ferraresso M, Rigotti P, Stepkowski SM, Chou TC, Kahan BD. Immunosuppressive effects of defibrotide. Transplantation. 1993;56:928\u201333.","journal-title":"Transplantation"},{"key":"203_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1043-6618(89)80007-6","volume":"21","author":"G Fumagalli","year":"1989","unstructured":"Fumagalli G, Sala C, Angelaccio E, Lombardo N, Clementi F. Thrombolytic activity of defibrotide: a morphometric evaluation in experimental venous thrombosis. Pharmacol Res. 1989;21:293\u20138.","journal-title":"Pharmacol Res"},{"key":"203_CR6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0165-2478(88)90141-1","volume":"19","author":"K Bendtzen","year":"1988","unstructured":"Bendtzen K. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett. 1988;19:183\u201391.","journal-title":"Immunol Lett"},{"key":"203_CR7","first-page":"551","volume":"12","author":"SR Dalmau","year":"1993","unstructured":"Dalmau SR, Freitas CS, Tabak DG. Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow. Bone Marrow Transplant. 1993;12:551\u201363.","journal-title":"Bone Marrow Transplant"},{"key":"203_CR8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2307\/3579282","volume":"145","author":"R Neta","year":"1996","unstructured":"Neta R, Keller JR, Ali N, Blanchette F, Dubois CM. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil. Radiat Res. 1996;145:624\u201331.","journal-title":"Radiat Res"},{"key":"203_CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.2042-7158.1995.tb05789.x","volume":"47","author":"H Schroder","year":"1995","unstructured":"Schroder H. Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity. J Pharm Pharmacol. 1995;47:250\u20132.","journal-title":"J Pharm Pharmacol"},{"key":"203_CR10","first-page":"122","volume":"38","author":"T Hohlfeld","year":"1992","unstructured":"Hohlfeld T, Bucha E, Nowak G, Bruggener E, Strobach H, Schror K. Favourable effect of defibrotide in lipid A-induced shock in pigs. Circ Shock. 1992;38:122\u20139.","journal-title":"Circ Shock"},{"key":"203_CR11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12185-014-1578-y","volume":"99","author":"N Maximova","year":"2014","unstructured":"Maximova N, Ferrara G, Minute M, et al. Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant. Int J Hematol. 2014;99:766\u201372.","journal-title":"Int J Hematol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-015-0203-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-015-0203-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-015-0203-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:56:07Z","timestamp":1559447767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-015-0203-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s12325-015-0203-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}